Adamas Pharmaceuticals Inc·4

Feb 3, 6:12 PM ET

Adamas Pharmaceuticals Inc 4

4 · Adamas Pharmaceuticals Inc · Filed Feb 3, 2015

Insider Transaction Report

Form 4
Period: 2015-02-02
Transactions
  • Sale

    Common Stock

    2015-02-02$16.77/sh3,000$50,31078,000 total
Holdings
  • Common Stock

    (indirect: Ivan Lieberburg and Janice Kirsch as CPWTROS)
    16,000
Footnotes (1)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_558341

    POA DOCUMENT